Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > AMRI > Summary

Albany Molecular Research Inc.
(AMRI)

8.58USD   Up0.06 (0.70%)   
On Nov 26
 Albany Molecular Research Inc. (NasdaqNM:AMRI) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 8.58USD
Trade Time:Nov 26
Change:Up0.06 (0.70%)
Prev Close:8.52
Open:8.55
Bid:8.30 x 200
Ask:9.42 x 200
1y Target Est:8.00
Day's Range:8.45 - 8.70
52wk Range:7.31 - 12.56
Volume:30,068
Avg Vol (3m):99,374.2
Market Cap:271.50M
P/E (ttm):47.40
EPS (ttm):0.18
Div & Yield:N/A (N/A%)
Add AMRI to Portfolio   Download Data

HEADLINES

 
•ALBANY MOLECULAR RESEARCH INC Financials - EDGAR Online Financials  - Fri, Nov 13
•AMRI’s quarterly earnings, revenue down - bizjournals.com  - Mon, Nov 9
•ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements - EDGAR Online  - Mon, Nov 9
•Q3 2009 Albany Molecular Research Earnings Release - Before Market Open - CCBN  - Mon, Nov 9
•AMRI Announces Third Quarter 2009 Results - Business Wire  - Mon, Nov 9
•AMRI receives $750K milestone payment - bizjournals.com  - Mon, Nov 2
•Third Compound from AMRI Bristol-Myers Squibb Collaboration Selected for Preclinical Development - Business Wire  - Mon, Nov 2
•AMRI to Present at the Oppenheimer 20th Annual Healthcare Conference - Business Wire  - Fri, Oct 30
•AMRI to Announce Third Quarter Results - Business Wire  - Mon, Oct 26
•Daines: Treat flu-like symptoms as H1N1 - bizjournals.com  - Fri, Oct 23
» More Headlines for AMRI...

ANALYST

 
EPS Est (next year) (Dec-09) :0.03
EPS Est (in 2 years) (Dec-10) :0.17
Avg Rec (current)*:3.0
PEG Ratio:28.40
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States and Europe.

» Full Company Profile